17-year follow-up of a randomized prospective controlled trial of adjuvant intravesical doxorubicin in the treatment of superficial bladder cancer.

Cheng, C W; Chan, P S; Chan, L W; Chan, C K; Ng, C F; Lai, M M

Cheng, C W; Chan, P S; Chan, L W; Chan, C K; Ng, C F; Lai, M M.

Affiliation

Cheng CW; Division of Urology, Department of Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China. drmcheng@hotmail.com

Int Braz J Urol ; 31(3): 204-11, 2005.

Article de En | MEDLINE | ID: mdl-15992422

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la vessie urinaire / Carcinome transitionnel / Doxorubicine / Antibiotiques antinéoplasiques Type d'étude: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Int Braz J Urol Sujet du journal: UROLOGIA Année: 2005 Type de document: Article Pays d'affiliation: Chine Pays de publication: Brésil

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links